Clinicopathologic correlation with MUC expression in advanced gastric cancer
- Author:
Kwang KIM
1
;
Kyeong Woon CHOI
;
Woo Yong LEE
Author Information
- Publication Type:Original Article
- Keywords: MUC; Stomach neoplasms; Prognosis; Retrospective analysis
- MeSH: Classification; Follow-Up Studies; Humans; Immunohistochemistry; Logistic Models; Multivariate Analysis; Prognosis; Proportional Hazards Models; Receptor, Epidermal Growth Factor; Stomach Neoplasms
- From: Korean Journal of Clinical Oncology 2018;14(2):89-94
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: To investigate the relationship between MUC expression and clinicopathologic factors in advanced gastric cancer.METHODS: A total of 237 tumor specimens were assessed for MUC expression by immunohistochemistry. The clinicopathologic factors were investigated with MUC1, MUC2, MUC5AC, and MUC6.RESULTS: MUC1, MUC2, MUC5AC, and MUC6 expression was identified in 148 of 237 (62.4%), 141 of 237 (59.5%), 186 of 237 (78.5%), and 146 of 237 (61.6%) specimens, respectively. MUC1 expression was correlated with age, human epidermal growth factor receptor 2 (HER2) status, lymphatic invasion, Lauren classification and histology. Further multivariate logistic regression analysis revealed a significant correlation between MUC1expression and lymphatic invasion, diffuse type of Lauren classification. MUC5AC expression was correlated with HER2 status, Lauren classification and histology. Further multivariate logistic regression analysis revealed a significant correlation between MUC5AC expression and HER2 status, diffuse and mixed type of Lauren classification. MUC2 and MUC6 expression were not correlated with clinicopathologic factors. The patients of MUC1 expression had poorer survival than those without MUC1 expression, but MUC2, MUC5AC or MUC6 were not related to survival. In an additional multivariate analysis that used the Cox proportional hazards model, MUC1 expression was not significantly correlated with patient survival independent of age, N-stage, and venous invasion.CONCLUSION: When each of these four MUCs expression is evaluated, in light of clinicopathologic factors, MUC1 expression may be considered as a prognostic factor in patients with advanced gastric cancer. Therefore, careful follow-up may be necessary because the prognosis is poor when MUC1 expression is present.
